Allison Gates
General Partner @ SemperVirens Venture Capital
San Francisco, United States
Allison Gates is a Series A investor at SemperVirens Venture Capital in San Francisco focused on Health Care and Medical. Allison Baum Gates is based out of San Francisco, California, and is the General Partner of SemperVirens Venture Capital. Allison previously worked at Fresco Capital as a Managing Partner and Co-Founder. Allison Baum Gates attended the Harvard University. Allison Baum Gates has received recognition as a Forbes 30 Under 30 honoree in Finance & Venture Capital and was named a Transform 10 Winner in 2023.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 45%
Last updated:
For AI agents: llms.txt
Industries Allison Gates invests in
Stages Allison Gates invests in
Countries Allison Gates invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (36%)
- Medical 3 (27%)
- mHealth 2 (18%)
- Recruiting 2 (18%)
- Apps 1 (9%)
Stage
- Series A 5 (45%)
- Seed 4 (36%)
- Series B 1 (9%)
- Series D 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| UpSmith is significantly enhancing lives by giving people access to training in practical skills and long-lasting careers. | $10M / Series A / Oct 05, 2026 | ||
| take2 is an online marketplace platform that provides a place for job seekers to display the skills required to land a job. | $14M / Series A / Feb 11, 2026 | ||
| Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $100M / Series D / Feb 03, 2026 | ||
| Trial Library is an oncology clinical trials company. | $10M / Series A / Dec 02, 2025 | ||
| Sully is deploying autonomous medical workers into healthcare organizations to address the most expensive line item in healthcare: payroll ($800b/yr in the US alone). Today, Sully's autonomous workers can perform most medical staff tasks 100x faster and 20x cheaper. From Digital Triage Nurses and Autonomous Medical Assistants to DigitalScribes and Digital Receptionists, our workers can automate patient check-in, assessments, documentation, diagnosis support, and billing that integrates with Electronic Health Records (EHRs) | Series A / Feb 10, 2025 | ||
| Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $63M / Series B / Apr 24, 2024 | ||
| take2 is an online marketplace platform that provides a place for job seekers to display the skills required to land a job. | $5M / Seed / Apr 16, 2024 | ||
| Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $25M / Series A / Sep 27, 2023 | ||
| Midi Health provides virtual healthcare services focused on midlife women’s health, especially around hormonal changes such as perimenopause and menopause, through personalized care plans delivered by clinicians trained in these areas. Its services include telehealth consultations that can integrate prescription support, supplements, lifestyleguidance, and symptom-specific treatments to address issues like weight, mood, sleep, and sexual wellness. Midi Health also offers tailored support protocols that consider an individual’s health history and goals to guide ongoing care. Its platform makes care accessible online and works with insurance for coverage of visits and prescriptions. The company additionally offers targeted supplements designed to complement its clinical care approach. | $14M / Seed / Oct 27, 2022 | ||
| Violet is a platform that helps the healthcare industry deliver more inclusive services. It enables identity-centered care for everyone. | $4.1M / Seed / Aug 15, 2022 | ||
| See all 11 investments → | |||
Co-Investors
SemperVirens is an early-stage ecosystem fund investing in workforce technology, healthcare technology, and financial technology companies looking to solve employer needs. Its team members bring deep industry experience, relationships, and insights.
SemperVirens Venture Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Allison Gates
General Partner
|
|||
Caribou Honig
Partner
|
|||
Christy Lake
HR Venture Advisor
|
|||
Colin Tobias
Principal
|
|||
Dermot J. O'Brien
Executive Advisory Board Member
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Allison Gates invest in?
Allison Gates invests primarily in Health Care, Medical and mHealth startups, most often at Series A and Seed stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Allison Gates?
Public channels for Allison Gates include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Allison Gates last invest?
The most recent investment recorded for Allison Gates closed in Oct 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
